BNP/CALL/STRYKER CORP./350/0.1/20.12.24 Stock

Warrant

DE000PN38H47

Delayed Deutsche Boerse AG 02:21:00 2024-07-09 am EDT
1.63 EUR +2.52% Intraday chart for BNP/CALL/STRYKER CORP./350/0.1/20.12.24
Current month-18.04%
1 month-36.14%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-09 1.63 +2.52%
24-07-08 1.59 -8.09%
24-07-05 1.73 +4.85%
24-07-04 1.65 +10.74%
24-07-03 1.49 -9.70%

Delayed Quote Deutsche Boerse AG

Last update July 09, 2024 at 02:21 am EDT

More quotes

Static data

Product typeWarrant Plain-Vanilla
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN38H4
ISINDE000PN38H47
Date issued 2023-06-02
Strike 350 $
Maturity 2024-12-20 (165 Days)
Parity 10 : 1
Emission price 1.29
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.05
Lowest since issue 0.66
Spread 0.1
Spread %5.78%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
334.1 USD
Average target price
372.7 USD
Spread / Average Target
+11.56%
Consensus